Coherus BioSciences, Inc. (Nasdaq: CHRS) announced that the United States Patent and Trademark Office (USPTO) issued to Coherus U.S. Patents ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE